Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts
2014 · British Journal of Cancer · 237 citations
https://doi.org/10.1038/bjc.2014.210
Y
Yifang Zhu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
722
Citations
11
h-index
12
i10-index
Yifang Zhu is an academic researcher from Peking University. The author has contributed to research in topics: Epigenetics and DNA Methylation & Histone Deacetylase Inhibitors Research & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 11, co-authored 34 publications.
ORCID: 0000-0002-1838-612XPapers by this author
worksIcariin displays anticancer activity against human esophageal cancer cells via regulating endoplasmic reticulum stress-mediated apoptotic signaling
2016 · Scientific Reports · 71 citations
https://doi.org/10.1038/srep21145
Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation
2016 · Scientific Reports · 69 citations
https://doi.org/10.1038/srep35196
Identification of clinical and pathological risk factors for lymph-node metastasis in T1 stage colon cancer: a population-based study
2025 · Updates in Surgery · 2 citations
https://doi.org/10.1007/s13304-025-02438-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat